Drugs / SCTB14
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06304818 | Apr 2024 → Dec 2027 expected | cancer | Sinocelltech Ltd. | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT07362459 | Dec 2025 → Jul 2027 expected | non-small cell lung carcinoma | Sinocelltech Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCTB14 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06304818 ↗ |
| Route | Intravenous | “SCTB14,IV” NCT06304818 ↗ |